Capecitabine Monotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Capecitabine Monotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer

Published:2004 Issue:3 Volume:21 Page:223-232
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:MO

Author:

Lee S.-H.,Lee J.,Park J.,Park S. H.,Lee K.-E.,Lee S. I.,Nam E.,Park J. O.,Kim K.,Jung C. W.,Park Y. S.,Yoon S. S.,Kang W. K.,Lee M. H.,Park K.,Im Y.-H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://www.springerlink.com/index/pdf/10.1385/MO:21:3:223

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer;Medical Oncology;2024-03-27

2. Novel and Simple Nomograms Using Inflammation and Nutritional Biomarkers for Stage II–III Colon Cancer, Taking “Time after Curative Surgery” into Consideration;Nutrition and Cancer;2022-04-11

3. Longitudinal efficacy and safety of capecitabine and cyclophosphamide as early-line treatment in patients with metastatic breast cancer: A prospective cohort study by the Kyushu Breast Cancer Study Group, Japan.;Annals of Cancer Research and Therapy;2022-01-31

4. A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence;Anticancer Research;2021-09

5. Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort;Journal of Cancer Research and Clinical Oncology;2021-01-20